Cancer BiologybioRxivPreprint
CBL mutations promote activation of PI3K/AKT signaling via LYN kinase
R. Belizaire, S. H. J. Koochaki, N. Udeshi…·B. L. Ebert
The paper investigates how CBL mutations drive oncogenesis by enhancing LYN kinase activity and PI3K/AKT signaling, suggesting LYN inhibition as a therapeutic strategy.
DOI 10.1101/2020.04.13.038448